cushieblog.com
ALD403 (migraine drug) and ALD1613 (for Cushing’s disease)
As it moves into crucial Phase 3 drug trials for its flagship migraine treatment, Bothell-based Alder Biopharmaceuticals (Nasdaq: ALDR) is looking to raise a lot of cash. Alder is offering up to $2…